RepliCel Announces Appointment of Leading Sports Medicine Expert as Orthopedics Clinical Advisor (Japan) May 3, 2021
RepliCel Life Sciences Announces Intention to Pay Dividend on Preferred Shares Mar 31, 2021 Life Science, Technology
RepliCel Presents Its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference Feb 18, 2021 Life Science, Technology
RepliCel Closes First Tranche of Strategic Investment Commitment Feb 10, 2021 Life Science, Technology
Healthcare Roundup – Pfizer runs early on schedule to supply 200M COVID vaccine doses to U.S. by May; Cassava surges after favorable trial data for simufilam in Alzheimer’s disease Feb 3, 2021 Life Science
Healthcare Roundup – Illumina surges after patent win; announces collaboration in China; BioCryst climbs after being named ‘the most undervalued stock in the market Feb 1, 2021 Life Science
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement Jan 25, 2021 Life Science
Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest Jan 21, 2021 Life Science
Healthcare Roundup – Gilead and VIR Biotechnology tie up in chronic hepatitis B virus cure setting, AstraZeneca’s COVID-19 vaccine is set for Indian rollout Jan 12, 2021 Life Science
Healthcare Roundup – CVS raised as Jefferies sees meaningful earning surprises; SoftBank takes stake in Pacific Biosciences Jan 9, 2021 Life Science
Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis Dec 22, 2020 Life Science
Healthcare Roundup – U.S. prepares for mass inoculations as COVID-19 vaccine rolls out, Bahrain OK’s Chinese COVID-19 vaccine for use Dec 14, 2020 Life Science
RepliCel Announces Adoption of Advance Notice Bylaw and Shareholder Rights Plan as well as Transitions in its Board of Directors Dec 11, 2020 Life Science